Armata Pharmaceuticals (ARMP) Stock Statistics & Valuation Metrics

Armata Pharmaceuticals has a market cap or net worth of $72.39M. The enterprise value is $144.14M.

Armata Pharmaceuticals has 36,193,478 shares outstanding. The number of shares has decreased by -2.65% in one year.

Armata Pharmaceuticals’s return on equity (ROE) is 0.39 and return on invested capital (ROIC) is -49.34%.

The current PE Ratio of Armata Pharmaceuticals is -3.54. Armata Pharmaceuticals’s PEG ratio is -2.63.

In the last 12 months, Armata Pharmaceuticals had revenue of 5.17M and earned -18.92M in profits. Earnings per share was -0.52.

In the last 12 months, operating cash flow was -34.55M and capital expenditures -1.73M, giving a free cash flow of -36.27M billion.

Armata Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Armata Pharmaceuticals upcoming earnings date is Aug 13, 2025, TBA Not Confirmed.

Armata Pharmaceuticals as a current ratio of 0.23, with Debt / Equity ratio of -198.88%

In the past 12 months, Armata Pharmaceuticals has paid 0.00 in taxes.

Armata Pharmaceuticals EV to EBITDA ratio is -26.88, with an EV/FCF ratio of -4.67.

Armata Pharmaceuticals has $11.69M in cash and marketable securities with $106.96M in debt, giving a net cash position of $95.28M billion.

Gross margin is 43.72%, with operating margin of -820.18%, and net profit margin of -365.60%.

The average price target for Armata Pharmaceuticals is $9.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy